Please assess the completion status of the following clinical trial:

Trial Title: Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Positive blood culture with Gram stain showing GNB identified during local laboratory business hours.~Exclusion Criteria:~* Identification of GNB outside of local laboratory business hours (e.g. whenever laboratories are staffed to perform both rapid testing and routine testing)~* Positive blood culture for GNB at the same institution within prior 7 days (if known at the time of randomization).~* Deceased at the time of randomization.~* GNB plus gram-positive organism, gram-negative cocci, and/or yeast detected on Gram stain~* Previous enrollment in this study~* No Minnesota research authorization (Rochester site only)

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard blood culture and AST (Type: ACTIVE_COMPARATOR): Standard blood culture and antimicrobial susceptibility testing (AST), and antimicrobial stewardship.
- Rapid organism identification and AST (Type: ACTIVE_COMPARATOR): Rapid organism identification and AST using the Accelerate PhenoTest™ BC Kit, performed on the Accelerate Pheno™ System (AXDX), and antimicrobial stewardship. The blood sample will also undergo standard culture and AST in addition to the rapid testing.

Based on this trial design, predict the completion outcome and termination type (if applicable).